Experiment: 2L41

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
2	2D 1H-1H TOCSY	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
3	3D HNCA	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
4	3D HNCACB	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
5	3D CBCA(CO)NH	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
6	3D HNHA	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
7	3D HCCH-TOCSY	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
8	2D HB(CB)(CGCD)HD	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
9	3D 1H-13C NOESY	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
10	3D 1H-15N NOESY	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
11	2D F1 filtered F2 filtered	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303
12	2D F1 filtered F2 edited	2.5mM [U-99% 13C; U-99% 15N] Nab3 RRM-1, 2.5mM RNA-2, 50mM sodium phosphate buffer(pH 7.5)-3, 150mM sodium chloride-4, 10mM beta-mercaptoethanol-5	90% H2O/10% D2O		7.5	ambient	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
molecular dynamics	Structures refined in explicit solvent	CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	60
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	processing	TopSpin	2.1	Bruker Biospin
3	collection	TopSpin	2.1	Bruker Biospin
4	chemical shift assignment	Sparky	3.0	Goddard
5	data analysis	Sparky	3.0	Goddard
6	peak picking	Sparky	3.0	Goddard
7	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
8	refinement	Amber	10	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm
9	geometry optimization	Amber	10	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm
10	data analysis	WHAT IF		Vriend

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.